← Portfolio Scout

Portfolio company

Vicebio

United Kingdom · £79.0m raised

Raised

£79.0m

Latest stage

Series B

Rounds recorded

1

Backed by

2 investors

Sectors

Digital Health

About

This biopharmaceutical company develops multivalent vaccines for respiratory viral infections targeting older adults and immunocompromised patients.

Source

Funding history · 1

  1. 2024-09-23Series B$100m

Similar companies